Issue Information

Issue Information
Published: (2025)

Issue Information
Published: (2025)

Issue Information
Published: (2025)

Issue Information
Published: (2026)

Issue Information
Published: (2024)

Issue Information
Published: (2026)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2026)

Issue Information
Published: (2026)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
by: Atif Siddiqui
Published: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
by: Jiwon Kim, et al.
Published: (2025)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
by: Nicolette Centanni, et al.
Published: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
by: Yi‐Fan Chien, et al.
Published: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
by: Amanda Massmann, et al.
Published: (2025)

In Search of Big Beautiful Biomarkers
by: C. Lindsay DeVane
Published: (2025)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
by: Nihal El Rouby, et al.
Published: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
by: Trisha Matsuura, et al.
Published: (2025)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
by: Kathleen A. Stringer, et al.
Published: (2025)

Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy
by: Ashwin Karanam, et al.
Published: (2025)

Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors
by: Kellye Eagan, et al.
Published: (2025)

Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or Remitted Depression”
Published: (2025)

Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation
by: Spenser E. January, et al.
Published: (2025)

Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study
by: Yaping Zhan, et al.
Published: (2025)

Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐ and Full‐Thickness Skin Burns
by: Ronald G. Hall, et al.
Published: (2025)

Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations
by: Aditi Shendre, et al.
Published: (2025)

Oritavancin for Treatment of Osteomyelitis: A Systematic Review and Meta‐Analysis of Observational Studies
by: Martin Krsak, et al.
Published: (2025)

Proton pump inhibitor concomitant use to prevent oxaliplatin‐induced peripheral neuropathy: Clinical retrospective cohort study
by: Keisuke Mine, et al.
Published: (2025)

Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex
by: Wesley D. Kufel, et al.
Published: (2025)

Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study
by: Arden R. Barry, et al.
Published: (2025)

Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double‐blind placebo‐controlled crossover trial
by: Ian R. Woodcock, et al.
Published: (2025)

Comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
by: João Gama Marques, et al.
Published: (2025)